“Extrauterine growth restriction” and “postnatal growth failure” are misnomers for preterm infants
Tanis R. Fenton(University of Calgary), Prakesh S. Shah(Mount Sinai Hospital), Dena Goldberg(Unknown), Sarah N. Taylor(Yale University), Seham Elmrayed(University of Calgary), Misha Eliasziw(Tufts University), Ian J. Griffin(University of California, Davis), Diane Anderson(Baylor College of Medicine), Nicholas D. Embleton(Royal Victoria Infirmary), David H. Adamkin(University of Louisville), Niels Rochow(McMaster University), Roseann Nasser(Saskatchewan Health Authority), Sharon Groh‐Wargo(Case Western Reserve University), Barbara E. Cormack(University of Auckland), Frank H. Bloomfield(University of Auckland), Ángela Hoyos(Universidad El Bosque), Belal Alshaikh(Alberta Children's Hospital), William W. Hay(University of Colorado Denver), Richard J. Schanler(Northwell Health), Thibault Senterre(University of Liège)
Cited by 151
Related Papers
Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis
|Nature|1988|833
Stillbirths: recall to action in high-income countries
|The Lancet|2016|689
Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States
|PEDIATRICS|2016|327
INTERGROWTH-21st very preterm size at birth reference charts
|The Lancet|2016|309